Asset Details
Do you wish to reserve the book?
Human-level COVID-19 diagnosis from low-dose CT scans using a two-stage time-distributed capsule network
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Human-level COVID-19 diagnosis from low-dose CT scans using a two-stage time-distributed capsule network
Do you wish to request the book?
Human-level COVID-19 diagnosis from low-dose CT scans using a two-stage time-distributed capsule network
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Human-level COVID-19 diagnosis from low-dose CT scans using a two-stage time-distributed capsule network
2022
Overview
Reverse transcription-polymerase chain reaction is currently the gold standard in COVID-19 diagnosis. It can, however, take days to provide the diagnosis, and false negative rate is relatively high. Imaging, in particular chest computed tomography (CT), can assist with diagnosis and assessment of this disease. Nevertheless, it is shown that standard dose CT scan gives significant radiation burden to patients, especially those in need of multiple scans. In this study, we consider low-dose and ultra-low-dose (LDCT and ULDCT) scan protocols that reduce the radiation exposure close to that of a single X-ray, while maintaining an acceptable resolution for diagnosis purposes. Since thoracic radiology expertise may not be widely available during the pandemic, we develop an Artificial Intelligence (AI)-based framework using a collected dataset of LDCT/ULDCT scans, to study the hypothesis that the AI model can provide human-level performance. The AI model uses a two stage capsule network architecture and can rapidly classify COVID-19, community acquired pneumonia (CAP), and normal cases, using LDCT/ULDCT scans. Based on a cross validation, the AI model achieves COVID-19 sensitivity of
89.5
%
±
0.11
, CAP sensitivity of
95
%
±
0.11
, normal cases sensitivity (specificity) of
85.7
%
±
0.16
, and accuracy of
90
%
±
0.06
. By incorporating clinical data (demographic and symptoms), the performance further improves to COVID-19 sensitivity of
94.3
%
±
0.05
, CAP sensitivity of
96.7
%
±
0.07
, normal cases sensitivity (specificity) of
91
%
±
0.09
, and accuracy of
94.1
%
±
0.03
. The proposed AI model achieves human-level diagnosis based on the LDCT/ULDCT scans with reduced radiation exposure. We believe that the proposed AI model has the potential to assist the radiologists to accurately and promptly diagnose COVID-19 infection and help control the transmission chain during the pandemic.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
